News

Article

AJMC® in the Press, May 10, 2024

Author(s):

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

An article from Memory Care Business referenced a review published in a September 2022 supplement to The American Journal of Managed Care® (AJMC®) focusing on advancing Alzheimer disease treatment. The supplement article, “The Economic and Societal Burden of Alzheimer Disease: Managed Care Considerations,” highlighted that Alzheimer disease treatment could cost an estimated $321 billion in 2022, with costs expected to increase to $1 trillion in 2050.

An article from Business A.M. referenced a contributor article published on AJMC.com, the website of AJMC. The article, “Contributor: In the Misdiagnosis of Menopause, What Needs to Change?” highlighted that 80% of medical residents felt barely comfortable discussing menopause and only 20% of residency programs for obstetrics and gynecology offered menopause training.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
1 expert in this video
4 experts in this video
1 expert in this video
4 experts in this video
1 expert is featured in this series.
Merrill H. Stewart, MD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo